YOLFTbeta
GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS · NASDAQ · Healthcare / Diagnostics & Research

52.37USD+0.50 (+0.96%)

Price History

Full chart

Market Stats

Previous Close51.87
Open51.01
Day Range48.42 – 52.59
52-Week Range32.21 – 170.87
Volume1.12M
Market Cap2.05B
P/E (TTM)0.00
Forward P/E63.29
EPS-3.63
Dividend Yield0.00%
Beta1.97
50-Day Avg81.93
200-Day Avg75.95

About

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMs. Katherine A. Stueland
  • Employees1.30K
  • HeadquartersNorth Tower, Stamford, CT, United States, 06902, USA
  • Websitehttps://www.genedx.com

Leadership

  • Ms. Katherine A. StuelandCEO & Director · b. 1976
  • Mr. Kevin Feeley CPAChief Financial Officer · b. 1981
  • Dr. Bryan M. Dechairo Ph.D.Chief Technology & Innovation Officer · b. 1973
  • Mr. Mark A. Gardner M.B.A.President · b. 1966
  • Ms. Sabrina V. DunbarDirector of Investor Relations & Communications
  • Ms. Heidi C. Chen J.D.Chief Legal Officer · b. 1967
  • Ms. Jami BiliboacaChief People Officer
  • Ms. Melanie DuquetteChief Growth Officer
  • Ms. Lisa GurryChief Business Officer
  • Ms. Linda Genen M.D., M.P.H.Chief Medical Officer

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue196.17M179.32M212.19M234.69M202.57M305.45M427.54M
Growth (%)--8.59%+18.33%+10.60%-13.69%+50.79%+39.97%
Cost of Revenue113.39M175.30M228.80M261.44M112.56M111.05M129.37M
Gross Profit82.78M4.03M-16.60M-26.75M90.01M194.40M298.17M
Gross Margin42.20%2.25%-7.82%-11.40%44.43%63.64%69.74%
Operating Expense113.20M246.02M429.55M640.90M270.60M217.61M309.98M
Operating Income-30.41M-241.99M-446.15M-667.65M-180.60M-23.21M-11.80M
Operating Margin-15.50%-134.95%-210.25%-284.48%-89.15%-7.60%-2.76%
EBITDA-22.51M-227.13M-220.75M-398.20M-136.46M-27.64M6.63M
EBITDA Margin-11.48%-126.66%-104.03%-169.67%-67.37%-9.05%1.55%
Net Income-29.70M-241.34M-245.39M-548.98M-175.77M-52.29M-21.02M
Net Income Margin-15.14%-134.58%-115.64%-233.91%-86.77%-17.12%-4.92%
R&D34.91M72.70M105.16M86.20M58.27M45.72M72.03M
R&D as % of Total Revenue17.80%40.54%49.56%36.73%28.76%14.97%16.85%
Interest Expense783.00K2.47M2.83M3.21M-3.03M2.54M
Interest Expense % of Total Revenue0.40%1.38%1.34%1.37%-0.99%0.59%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-251.64M554.09M545.26M418.76M419.38M570.19M
Total Liabilities-247.25M165.99M291.56M190.74M174.13M262.01M
Total Equity-4.39M388.10M253.71M228.02M245.25M308.18M
Cash-108.13M400.57M137.40M99.68M85.21M105.00M
Total Debt-43.26M32.85M77.13M119.77M116.17M151.95M
Net Debt--64.88M-367.72M-60.27M20.09M30.96M46.95M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-18.73M-93.13M-190.43M-319.15M-180.15M-28.50M33.28M
Investing Cash Flow-15.46M-31.97M-20.79M-141.33M-43.73M-30.13M-61.52M
Financing Cash Flow148.01M129.06M493.73M197.31M186.24M44.16M48.02M
Capital Expenditure15.46M31.97M20.79M14.32M5.71M5.49M19.02M
Free Cash Flow-34.18M-125.10M-211.22M-333.48M-185.86M-33.99M14.26M
FCF to OCF182.53%134.33%110.92%104.49%103.17%119.27%42.86%

Earnings

Report DateNov 16, 2020Mar 30, 2021May 24, 2021Jul 21, 2021Nov 15, 2021Mar 14, 2022May 12, 2022Aug 15, 2022Nov 14, 2022Mar 14, 2023May 9, 2023Aug 8, 2023Oct 30, 2023Feb 20, 2024Apr 29, 2024Jul 30, 2024Oct 29, 2024Feb 18, 2025Apr 30, 2025Jul 29, 2025Oct 28, 2025Feb 23, 2026May 4, 2026Aug 3, 2026Oct 27, 2026
EPS Estimate0.000.000.000.00-5.28-0.26-9.24-5.61-5.28-0.16-1.48-1.31-1.31-0.75-0.67-0.30-0.210.100.090.110.420.12-0.05-0.190.07
EPS Actual0.00-0.00-1.06-0.21-16.06-0.17-8.84-7.12-6.65-0.25-2.90-1.77-0.82-0.69-0.33-0.100.040.640.270.500.490.14-0.280.01-
Surprise-----204.17%34.62%4.33%-26.92%-25.95%-56.25%-95.95%-35.11%37.40%8.00%50.75%66.67%119.05%515.00%200.00%354.55%16.67%16.67%-465.66%105.26%-
Timing-After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap2.05B
Enterprise Value2.58B
Trailing P/E0.00
Forward P/E63.29
Price / Sales4.50
Price / Book10.40
EPS-3.63
Book Value8.19
Revenue (TTM)454.43M
Gross Profit (TTM)315.30M
EBITDA-33.70M
Profit Margin-23.41%
Operating Margin-15.21%
Return on Equity-40.80%
Return on Assets-7.89%
Shares Outstanding29.82M
Shares Float20.44M
Beta1.97
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 8 analystsTarget 93.50
  • Strong Buy
    7
  • Buy
    1

Ownership Breakdown

Institutions
107.71%
Insiders
7.71%
Retail / Other
0.00%

Top Institutional Holders

  • Corvex Management LP
    4.78M16.04%
  • Casdin Capital, LLC
    3.71M12.43%
  • BlackRock Inc
    1.71M5.72%
  • The Goldman Sachs Group Inc
    1.67M5.60%
  • ARK Investment Management LLC
    1.61M5.40%
  • William Blair Investment Management, LLC
    1.40M4.70%
  • Morgan Stanley - Brokerage Accounts
    988.30K3.31%
  • Vanguard Capital Management, LLC
    879.00K2.95%
  • Citadel Advisors Llc
    865.46K2.90%
  • First Light Asset Management, LLC
    783.92K2.63%
  • Deep Track Capital, LP
    700.00K2.35%
  • Sumitomo Mitsui Trust Group Inc
    666.58K2.24%
  • Amova Asset Management Americas, Inc
    666.58K2.24%
  • Assenagon Asset Management SA
    606.87K2.03%
  • Zweig-DiMenna Associates LLC
    571.95K1.92%
  • Geode Capital Management, LLC
    552.13K1.85%
  • State Street Corp
    527.82K1.77%
  • Gagnon Securities LLC
    524.87K1.76%

Top Fund Holders

  • ARK Innovation ETF
    1.08M3.64%
  • Vanguard MStar Total Stk Mkt Idx Invest
    607.77K2.04%

Stock Splits

  • May 4, 20231:33